Shahin Akhondzadeh

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 49

Top Venues

Psychiatry and clinical neurosciences

Archives of Iranian medicine

Journal of clinical pharmacy and therapeutics

Expert opinion on pharmacotherapy

Tehran University of Medical Sciences

University of Glasgow (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tehran University of Medical Sciences Sep 01 1995

Iran

Prof. of Clinical Psychopharmacology :: Psychiatry

Education History

University of Glasgow Mar 01 1993 - Mar 01 1995

United Kingdom

PHD :: Pharmacology

Publications

Ahmad Shamabadi, Razman Arabzadeh Bahri, Hanie Karimi, Ehsan Heidari, Shahin Akhondzadeh
Emerging pharmacotherapy for the treatment of cannabis use disorder. Expert opinion on pharmacotherapy 25 (6) (2024)
Ahmad Shamabadi, Hanie Karimi, Razman Arabzadeh Bahri, Mohsen Motavaselian, Shahin Akhondzadeh
Emerging drugs for the treatment of irritability associated with autism spectrum disorder. Expert opinion on emerging drugs 29 (1) (2024)
Ahmad Shamabadi, Hanie Karimi, Razman Arabzadeh Bahri, Mohsen Motavaselian, Shahin Akhondzadeh
Emerging drugs for the treatment of irritability associated with autism spectrum disorder. Expert opinion on emerging drugs 29 (1) (2024)
Ahmad Shamabadi, Razman Arabzadeh Bahri, Hanie Karimi, Ehsan Heidari, Shahin Akhondzadeh
Emerging pharmacotherapy for the treatment of cannabis use disorder. Expert opinion on pharmacotherapy (2024)
Ahmad Shamabadi, Hanie Karimi, Razman Arabzadeh Bahri, Mohsen Motavaselian, Shahin Akhondzadeh
Emerging drugs for the treatment of irritability associated with autism spectrum disorder. Expert opinion on emerging drugs (2024)
Ahmad Shamabadi, Razman Arabzadeh Bahri, Hanie Karimi, Ehsan Heidari, Shahin Akhondzadeh
Emerging pharmacotherapy for the treatment of cannabis use disorder. Expert opinion on pharmacotherapy (2024)
Ahmad Shamabadi, Hanie Karimi, Razman Arabzadeh Bahri, Mohsen Motavaselian, Shahin Akhondzadeh
Emerging drugs for the treatment of irritability associated with autism spectrum disorder. Expert opinion on emerging drugs (2024)
Ahmad Shamabadi, Razman Arabzadeh Bahri, Hanie Karimi, Ehsan Heidari, Shahin Akhondzadeh
Emerging pharmacotherapy for the treatment of cannabis use disorder. Expert opinion on pharmacotherapy 25 (6) (2024)
Sophia Esalatmanesh, Ladan Kashani, Shahin Akhondzadeh
Celecoxib in Treatment of Postpartum Depression: A Case Report. Archives of Iranian medicine 26 (5) (2023)
Hossein Sanjari Moghaddam, Shahin Akhondzadeh
Response to [Palmitoylethanolamide: one molecule, different formulations]. Psychiatry and clinical neurosciences 77 (2) (2023)
Sophia Esalatmanesh, Ladan Kashani, Maryam Khooshideh, Hossein Sanjari Moghaddam, Sahar Ansari, Shahin Akhondzadeh
Efficacy and safety of celecoxib for treatment of mild to moderate postpartum depression: a randomized, double-blind, placebo-controlled trial. Archives of gynecology and obstetrics (2023)
Ahmad Shamabadi, Setareh Fattollahzadeh-Noor, Bita Fallahpour, Fatemeh A Basti, Mohammad-Reza Khodaei Ardakani, Shahin Akhondzadeh
L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial. Psychopharmacology (2023)
Shahin Akhondzadeh
What is the Tolerance Limit of the Human Society in Face of the Killing of Innocent and Defenseless People of Gaza? Stop the Killing of Children and Infants in Gaza. Archives of Iranian medicine 26 (11) (2023)
Sophia Esalatmanesh, Ladan Kashani, Shahin Akhondzadeh
Celecoxib in Treatment of Postpartum Depression: A Case Report. Archives of Iranian medicine 26 (5) (2023)
Shahin Akhondzadeh
What is the Tolerance Limit of the Human Society in Face of the Killing of Innocent and Defenseless People of Gaza? Stop the Killing of Children and Infants in Gaza. Archives of Iranian medicine 26 (11) (2023)
Mehran Nematizadeh, Hossein Ghorbanzadeh, Hossein Sanjari Moghaddam, Mohammadreza Shalbafan, Mahsa Boroon, Amir-Abbas Keshavarz-Akhlaghi, Shahin Akhondzadeh
L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: a placebo-controlled, double-blind, randomized trial. Psychiatry and clinical neurosciences (2023)
Hossein Sanjari Moghaddam, Shahin Akhondzadeh
Response to [Palmitoylethanolamide: one molecule, different formulations]. Psychiatry and clinical neurosciences 77 (2) (2023)
Hossein Sanjari Moghaddam, Shahin Akhondzadeh
Response to [Palmitoylethanolamide: one molecule, different formulations]. Psychiatry and clinical neurosciences 77 (2) (2023)
Shahin Akhondzadeh
What is the Tolerance Limit of the Human Society in Face of the Killing of Innocent and Defenseless People of Gaza? Stop the Killing of Children and Infants in Gaza. Archives of Iranian medicine 26 (11) (2023)
Hossein Sanjari Moghaddam, Shahin Akhondzadeh
Response to [Palmitoylethanolamide: one molecule, different formulations]. Psychiatry and clinical neurosciences (2023)
Sophia Esalatmanesh, Ladan Kashani, Shahin Akhondzadeh
Celecoxib in Treatment of Postpartum Depression: A Case Report. Archives of Iranian medicine 26 (5) (2023)
Talieh Abedini, Reyhaneh Hosseyni, Farnaz Ghannadi, Hossein Sanjari Moghaddam, Mohammad-Reza Khodaei Ardakani, Ali Talaei, Shahin Akhondzadeh
Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial. Psychiatry and clinical neurosciences 76 (10) (2022)
Aida Khadivi, Parnian Shobeiri, Sara Momtazmaneh, Farhaneh-Sadat Samsami, Mohammadreza Shalbafan, Elham Shirazi, Shahin Akhondzadeh
Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial. Psychopharmacology 239 (2) (2022)
Rahim Badrfam, Seyed-Ali Mostafavi, Ali Khaleghi, Shahin Akhondzadeh, Atefeh Zandifar, Malihe Farid, Nami Mohammadian Khonsari, Mohammad Reza Mohammadi
The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial. Brain and behavior 11 (11) (2021)
Mohammad Dehghani, Mehdi Kahouei, Shahin Akhondzadeh, Bita Mesgarpour, Reza Ferdousi
Expectations of Health Researchers From Academic Social Network Sites: Qualitative Study. Journal of medical Internet research 23 (12) (2021)
Alia Saberi, Shahin Akhondzadeh, Samira Kazemi, Samaneh Kazemi
Infectious Agents and Stroke: A Systematic Review. Basic and clinical neuroscience 12 (4) (2021)
Fatemeh Ghazizadeh-Hashemi, Sayna Bagheri, Amir Ashraf-Ganjouei, Kamyar Moradi, Nazila Shahmansouri, Maryam Mehrpooya, Ahmad-Ali Noorbala, Shahin Akhondzadeh
Efficacy and safety of sulforaphane for treatment of mild to moderate depression in patients with history of cardiac interventions: A randomized, double-blind, placebo-controlled clinical trial. Psychiatry and clinical neurosciences 75 (8) (2021)
Mohammad Dehghani, Bita Mesgarpour, Shahin Akhondzadeh, Saber Azami-Aghdash, Reza Ferdousi
How the US Sanctions Are Affecting the Health Research System in Iran? Archives of Iranian medicine 24 (2) (2021)
Ahmad Shamabadi, Shahin Akhondzadeh
Efficacy and tolerability of Lavandula angustifolia in treating patients with the diagnosis of depression: a systematic review of randomized controlled trials. Journal of complementary & integrative medicine (2021)
Ahmad Shamabadi, Shahin Akhondzadeh
The Necessity of Preserving the Research System in Emergency Eras. Archives of Iranian medicine 24 (7) (2021)
Sara Momtazmanesh, Zeinab Amirimoghaddam-Yazdi, Hossein Sanjari Moghaddam, Mohammad Reza Mohammadi, Shahin Akhondzadeh
Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial. Psychiatry and clinical neurosciences 74 (7) (2020)
Saba Hoobehfekr, Hossein Sanjari Moghaddam, Mohammadreza Shalbafan, Maryam Ghazizadeh Hashemi, Mohammad Mehdi Pirmoradi, Amirhossein Sakenian, Amirhossein Poopak, Shayan Kashefinejad, Masoomeh Yarahmadi, Shahin Akhondzadeh
Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial. Psychiatry and clinical neurosciences 75 (2) (2020)
Maryam Rafeiy-Torghabeh, Amir Ashraf-Ganjouei, Kamyar Moradi, Sayna Bagheri, Mohammad-Reza Mohammadi, Shahin Akhondzadeh
Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial. European child & adolescent psychiatry 30 (5) (2020)
Ehsan Moazen-Zadeh, Samaneh Bayanati, Kimia Ziafat, Farzin Rezaei, Bita Mesgarpour, Shahin Akhondzadeh
Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial. Journal of psychopharmacology (Oxford, England) 34 (5) (2020)
Firouzeh Borhannejad, Behnam Shariati, Sina Naderi, Mohammadreza Shalbafan, Amirhosein Mortezaei, Erfan Sahebolzamani, Atefe Saeb, Seyyed Hosein Mortazavi, Leila Kamalzadeh, Ali Aqamolaei, Ahmad Ali Noorbala, Alireza Namazi-Shabestari, Shahin Akhondzadeh
Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial. Journal of clinical pharmacy and therapeutics 45 (4) (2020)
Neda Batebi, Hossein Sanjari Moghaddam, Alireza Hasanzadeh, Yousef Fakour, Mohammad Reza Mohammadi, Shahin Akhondzadeh
Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial. Child psychiatry and human development 52 (5) (2020)
Alireza Noroozi, Seyed Abbas Motevalian, Mohammad-Reza Zarrindast, Javad Alaghband-Rad, Shahin Akhondzadeh
Adding extended-release methylphenidate to psychological intervention for treatment of methamphetamine dependence: A double-blind randomized controlled trial. Medical journal of the Islamic Republic of Iran 34 (2020)
Sara Dehbozorghi, Sayna Bagheri, Kamyar Moradi, Kamyar Shokraee, Mohammad-Reza Mohammadi, Shahin Akhondzadeh
Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial. Psychiatry and clinical neurosciences 73 (11) (2019)
Shahin Akhondzadeh, Seyed-Ali Mostafavi, Seyed Ali Keshavarz, Mohammad Reza Mohammadi, Saeed Hosseini, Mohammad Reza Eshraghian
A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression. Journal of clinical pharmacy and therapeutics 45 (1) (2019)
Seyedeh-Mahsa Mahdavinasab, Amene Saghazadeh, Nogol Motamed-Gorji, Salar Vaseghi, Mohammad-Reza Mohammadi, Rosa Alichani, Shahin Akhondzadeh
Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial. European child & adolescent psychiatry 28 (12) (2019)
Mohammadreza Shalbafan, Farzaneh Malekpour, Borna Tadayon Najafabadi, Kiandokht Ghamari, Seyed-Ali Dastgheib, Arash Mowla, Elham Shirazi, Mehrdad Eftekhar Ardebili, Maryam Ghazizadeh-Hashemi, Shahin Akhondzadeh
Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial. Journal of psychopharmacology (Oxford, England) 33 (11) (2019)
Fatemeh Hendouei, Hossein Sanjari Moghaddam, Mohammad Reza Mohammadi, Negin Taslimi, Farzin Rezaei, Shahin Akhondzadeh
Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial. Journal of clinical pharmacy and therapeutics 45 (2) (2019)
Azadeh Seddighnia, Borna Tadayon Najafabadi, Kiandokht Ghamari, Ahmad Ali Noorbala, Naser Ebrahimi Daryani, Ladan Kashani, Shahin Akhondzadeh
Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double-blind, placebo-controlled trial. Journal of clinical pharmacy and therapeutics 45 (1) (2019)
Sina Naderi, Heidar Faghih, Ali Aqamolaei, Seyyed Hosein Mortazavi, Amirhosein Mortezaei, Erfan Sahebolzamani, Farzin Rezaei, Shahin Akhondzadeh
Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control. Psychiatry and clinical neurosciences 73 (4) (2018)
Alireza Ghajar, Faezeh Gholamian, Maryam Tabatabei-Motlagh, Mohsen Afarideh, Farzin Rezaei, Maryam Ghazizadeh-Hashemi, Shahin Akhondzadeh
Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial. Human psychopharmacology 33 (4) (2018)
Mohammad-Hadi Farahzadi, Ehsan Moazen-Zadeh, Emran Razaghi, Mohammad-Reza Zarrindast, Reza Bidaki, Shahin Akhondzadeh
Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial. Journal of psychopharmacology (Oxford, England) 33 (3) (2018)
Ladan Kashani, Sophia Esalatmanesh, Farzaneh Eftekhari, Samrand Salimi, Tahereh Foroughifar, Farnaz Etesam, Hamideh Safiaghdam, Ehsan Moazen-Zadeh, Shahin Akhondzadeh
Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial. Archives of gynecology and obstetrics 297 (3) (2018)
Somaye Arabzadeh, Maryam Shahhossenie, Bita Mesgarpour, Farzin Rezaei, Mohammad Reza Shalbafan, Zahra Ghiasi, Shahin Akhondzadeh
L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study. Human psychopharmacology 32 (4) (2017)
Farzin Rezaei, Bita Mesgarpour, Alireza Jeddian, Atefeh Zeionoddini, Payam Mohammadinejad, Elaheh Salardini, Mona Shahriari, Arefeh Zeinoddini, Shahin Akhondzadeh
Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study. Human psychopharmacology 32 (4) (2017)

Shahin Akhondzadeh.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shahin Akhondzadeh